Home > Formulary : Adult > Recent Decisions > 2015 >
Decisions 13th October 2015
At the meeting that took place on 13th October, the following decisions were agreed:
New Drug Requests
Approved
Tiotropium & Olodaterol inhaler (Spoilto®) (TLS Bue)
- Approved for inclusion onto the formulary for maintenance of COPD
Glycopyrronium (oral) (TLS Amber 3 months)
- Approved for inclusion onto the formulary for the treatment of hypersalivation in motor neurone disease patients, and in patients with neurological conditions.
Ulipristal (TLS Red)
- Approved for inclusion onto the formulary for the intermittent treatment of uterine fibroids.
- SCP in development and when approved will be amber
Sodium oxybate
- The JFG clinically approved the addition of sodium oxybate, however a business case from NBT needs to be submitted to the CCG's for approval before it can be added to the formulary.
Shared Care Protocols/TLS Change in Status
Edoxaban
- New SCP approved for the treatment of DVT/PE approved.